Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BriaCell Therapeutics Corp. Common Shares
BCTX | US
3.09
USD0.01
0.32%
BCTX | US
Loading StockChartView...
About BriaCell Therapeutics Corp. Common Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/04/2024
As of date
08/06/2026
Close
3.09
Open
3.14
High
3.15
Low
3.05
BriaCell Therapeutics Corp. an immuno-oncology-focused biotechnology company engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver Canada.
View LessBCTX | US
Risk
121.4
Sharpe
-0.72
Luna's Score
36/100
Recommendation
Sell
Luna says (BCTX | US)
What's Working
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
65.2%1 month
121.4%3 months
88.4%6 months
132.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
17.03
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-1.38
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-35.25M
MarketCap
110.89M
MarketCap(USD)
110.89M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-206.01
Short ratio
0.04
Short perc.
1.56
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.65
Range1M
1.36
Range3M
1.67
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.30
Price X volume
283.02K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.38 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 17.03 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 88.42 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 110.89M | 3.66B | Emerging |
